Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4
The invention concerns safe non-interacting drug combinations of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which is (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5 -dihydroxyhept-6-enoic acid or a pharmaceutically acceptabl...
Saved in:
Main Authors | , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
03.01.2006
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The invention concerns safe non-interacting drug combinations of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which is (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5 -dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof (the Agent) and a drug which is either an inducer, inhibitor or a substrate of cytochrome P450, in particular cytochrome P450 isoenzyme 3A4. Particular combinations are useful in treating hyperlipidaemia in humans who are receiving immunosuppressive chemotherapy. A preferred combination is the Agent and a fibrate drug, the use of such a combination in treating hyperlipidaemia in mammals, and medicaments containing such a combination for use in such treatments. |
---|---|
AbstractList | The invention concerns safe non-interacting drug combinations of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which is (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5 -dihydroxyhept-6-enoic acid or a pharmaceutically acceptable salt thereof (the Agent) and a drug which is either an inducer, inhibitor or a substrate of cytochrome P450, in particular cytochrome P450 isoenzyme 3A4. Particular combinations are useful in treating hyperlipidaemia in humans who are receiving immunosuppressive chemotherapy. A preferred combination is the Agent and a fibrate drug, the use of such a combination in treating hyperlipidaemia in mammals, and medicaments containing such a combination for use in such treatments. |
Author | PEARS JOHN S SCHNECK DENNIS RAZA ALI HUTCHINSON HOWARD G TOUCHI AKIRA BABA TAKAHIKO |
Author_xml | – fullname: SCHNECK DENNIS – fullname: BABA TAKAHIKO – fullname: HUTCHINSON HOWARD G – fullname: TOUCHI AKIRA – fullname: PEARS JOHN S – fullname: RAZA ALI |
BookMark | eNqNTstqw0AQ86E99PUPc0zAA01sJ-2xj5Tem55CCGt7HA-sZ5bdNXT7lf2k2tAP6EFIQkLoOrsQFbrKfl79eIZGh5rFRFYJs3GeA8sZFrslbvFQ4qLEzo7q1fUkyS5xgxzUTT5ZXONhoNgnG0bb6RybgUWP4JLngVsWrDDZIywKn1dhCVjkFbbcp9brV-rJxWmPRLkB03ALRmYAS881R_X5JNuxIQ_qIYx1iN5EAu3AldU9TE9IvtNAUDyVt9llZ2yguz--yeBtt395R3J6ouBMQ0Lx9PmxeXxYr6rt86r4R-UXoLhkOg |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US6982157B1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US6982157B13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:20:48 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US6982157B13 |
Notes | Application Number: US20010889414 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060103&DB=EPODOC&CC=US&NR=6982157B1 |
ParticipantIDs | epo_espacenet_US6982157B1 |
PublicationCentury | 2000 |
PublicationDate | 20060103 |
PublicationDateYYYYMMDD | 2006-01-03 |
PublicationDate_xml | – month: 01 year: 2006 text: 20060103 day: 03 |
PublicationDecade | 2000 |
PublicationYear | 2006 |
RelatedCompanies | SHIONOGI & CO., LTD |
RelatedCompanies_xml | – name: SHIONOGI & CO., LTD |
Score | 2.6261258 |
Snippet | The invention concerns safe non-interacting drug combinations of a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, which is... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
Title | Drug combinations comprising (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methylsulfonyl)amino] pyrimidin-5-yl] (3r,5s) -3,5-dihydroxyhept-6-enoic acid and an inhibitor, inducer or substrate of p450 isoenzyme 3A4 |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060103&DB=EPODOC&locale=&CC=US&NR=6982157B1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEF6KinrzifXFHqS00EHNq82hiE1aRPCBWhFEZJPs2oW4CUmKxF_pT3I21upFD4FNAsOym5lvZzLzDSEHncg0eMhcYMwVYDnMAta1DTAcLnjIo45p6OLki0vnbGSdP9gPNSK_a2EqntC3ihwRNSpEfS8qe53-BLH8KrcyPwwkPkpOhnc9vzHzjnXbgobf7w2ur_wrr-F5vdFt4_Km57hdBLdOHx2leX2K1jT7g_u-LkpJfyPKcIUsXKMwVaySGldrZMn7bry2RhYvpv-7cThVvXydfPjZ5IXiJNGV_Yqy6RvNYojgQ5uDFnTg0YKmBSKeJJmmC1Bl3AIHZJ6gmUzLGAx41B2jyzifxEKnpLfYq1TJE01L3d0LYQxsKOMn2jSztp23KJhtGyI5LiOd7TLmaYHyuEpkSFkoI8qUvqhUYxmgacjaOIzwY8loktEcbVLFfUsTQVPLPqI4E67ey1dOzVNrg9Dh4M47A1ya59k2PI9uZ4tobpI5lSi-RWjIutExN1wnCF0LD29dJ3C4K2xXGCYTIqqT-p9itv95t0OWZ9EOc5fMFdmE7yH-F8F-tXOf7B-4PA |
link.rule.ids | 230,309,786,891,25594,76906 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swELcQQ8DbYKDBNvDDVLVST0A-m4dqokmrbqMFQYuQEKqcxF4tBSdKUk3hr-RP4hyg8LI9RHJi6WTZvs_c_Y6Q725sGjxiHjDmCbAcZgHr2AYYDhc84rFrGro4eTR2hlPr1419s0Lkay1MjRP6twZHRI6KkN_LWl5nb0GsoM6tLI5CiZ_SH4NJN2gsvWPdtqAR9Lr9i_Pg3G_4fnd61Rhfdh2vg8rN7aGj9MHV4Lzacrru6aKU7L1GGXwkaxdITJVbZIWrbbLhvzZe2ybro5f_3Th8Yb3iE3kM8sUfiotEV_Y5yqZfNIohKh_a7LfAhVsLmhaIZJHmGi5AVUkLHJBFimIyqxIw4FZ3jK6SYpEInZLeYvdSpXc0q3R3L1RjYEOV3NGmmbftokXBbNsQy3kV62yXOc9KpMdVKiPKIhlTpvRDpZrLEEVD3sZhjJclp2lOC5RJNfYtTQXNLPuY4kq4eqjuOTVPrR1CB_2JPwTcmtnyGGbTq-UmmrtkVaWKfyY0Yp34hBueE0aehcZbxwkd7gnbE4bJhIj3yN4_yez_Z-6QbAwno7PZ2c_x7y9kcxn5ML-S1TJf8G9oC5ThQX2KT7Xpuyk |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Drug+combinations+comprising+%28E%29-7-%5B4-%284-fluorophenyl%29-6-isopropyl-2-%5Bmethylsulfonyl%29amino%5D+pyrimidin-5-yl%5D+%283r%2C5s%29+-3%2C5-dihydroxyhept-6-enoic+acid+and+an+inhibitor%2C+inducer+or+substrate+of+p450+isoenzyme+3A4&rft.inventor=SCHNECK+DENNIS&rft.inventor=BABA+TAKAHIKO&rft.inventor=HUTCHINSON+HOWARD+G&rft.inventor=TOUCHI+AKIRA&rft.inventor=PEARS+JOHN+S&rft.inventor=RAZA+ALI&rft.date=2006-01-03&rft.externalDBID=B1&rft.externalDocID=US6982157B1 |